Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02203526
Brief Title: Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma

First Submitted : July 29, 2014
First Submitted that Met QC Criteria : July 29, 2014
First Posted : July 30, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : August 11, 2020
Last Update Posted : August 12, 2020